Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

Antimicrob Agents Chemother. 2017 May 24;61(6):e00258-17. doi: 10.1128/AAC.00258-17. Print 2017 Jun.
No abstract available

Keywords: Mycobacterium tuberculosis; multidrug resistance; pyrazinamide.

Publication types

  • Letter
  • Comment

MeSH terms

  • Amidohydrolases / genetics
  • Antitubercular Agents
  • Humans
  • Microbial Sensitivity Tests
  • Mutation
  • Mycobacterium tuberculosis
  • Pyrazinamide*
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Amidohydrolases